Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today.
Total revenues inched up 1% year-over-year to $12.3 billion.
Net earnings attributable to BMS were $1.31 billion, or $0.64 per share, compared to $1.68 billion, or $0.83 per share, last year. Adjusted EPS decreased 29% to $1.46.
Bristol Myers Squibb expects full-year 2025 revenue to range between $46.5-47.5 billion and adjusted EPS to range between $6.35-6.65.
JPMorgan Chase will extend a $1.5 trillion investment program designed to bolster U.S. economic resilience across Europe, the Wall Street...
A total of 7.4 million Americans aged 65 and older are living with Alzheimer’s disease in 2026, an increase of...
Power Integrations, Inc. (NASDAQ: POWI) surged 5.6% Monday to $61.91 as a broad rally swept through semiconductor peers, with the...
SiTime Corporation (NASDAQ: SITM) surged 5.3% to $530.13 on Monday, extending the uptrend after Stifel recently lifted its price target...
U.S. importers, ranging from Target to Walmart, are due more than $160 billion in tariff refunds following a February Supreme...
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
